Increased risk of methemoglobinemia; drugs associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Lidocaine Patch 5% Interactions
Brand names: Lidoderm
Amide Local Anesthetic · Antiarrhythmic
Route: Topical
Contraindications
CONTRAINDICATIONS LIDODERM is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.
Pregnancy & Breastfeeding
Pregnancy Teratogenic Effects Pregnancy Category B. LIDODERM (lidocaine patch 5%) has not been studied in pregnancy. Reproduction studies with lidocaine have been performed in rats at doses up to 30 mg/kg subcutaneously and have revealed no evidence of harm to the fetus due to lidocaine. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, LIDODERM should be used during pregnancy only if clearly needed.
32 interactions on record
Increased risk of methemoglobinemia; antibiotics associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; local anesthetics have additive risk when used concomitantly.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; local anesthetics have additive risk when used concomitantly.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; local anesthetics have additive risk when used concomitantly.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antimalarials associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antineoplastic agents associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antibiotics associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antineoplastic agents associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antineoplastic agents associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antineoplastic agents associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; local anesthetics have additive risk when used concomitantly.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; drugs associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; nitrates/nitrites may cause methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antibiotics associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; nitrates/nitrites may cause methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; nitrates/nitrites may cause methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; nitrates/nitrites may cause methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antibiotics associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; anticonvulsants associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; anticonvulsants associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; local anesthetics have additive risk when used concomitantly.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antimalarials associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; local anesthetics have additive risk when used concomitantly.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; drugs associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; antineoplastic agents associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; local anesthetics have additive risk when used concomitantly.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; drugs associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia when concurrently exposed; local anesthetics have additive risk when used concomitantly.
Source: NLP:lidocaine patch 5%
Increased risk of methemoglobinemia; anticonvulsants associated with methemoglobinemia when used with local anesthetics.
Source: NLP:lidocaine patch 5%
Lidocaine Patch 5% + MexiletineModerate
Toxic effects are additive and potentially synergistic; use with caution in patients receiving Class I antiarrhythmic drugs.
Source: NLP:lidocaine patch 5%
Lidocaine Patch 5% + TocainideModerate
Toxic effects are additive and potentially synergistic; use with caution in patients receiving Class I antiarrhythmic drugs.
Source: NLP:lidocaine patch 5%